|
|
| G
|
Ada
|
adenosine deaminase
|
decreases metabolic processing increases metabolic processing
|
ISO
|
ADA alternative form results in decreased metabolism of Adenosine ADA protein results in increased metabolism of Adenosine
|
CTD |
PMID:16221767 |
|
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
multiple interactions affects binding
|
ISO EXP
|
Adenosine analog binds to and affects the activity of ADORA1 protein; Adenosine analog binds to and results in decreased activity of ADORA1 protein; PD 81723 affects the reaction [Adenosine analog binds to and affects the activity of ADORA1 protein]; VUF 5455 affects the reaction [Adenosine analog binds to and affects the activity of ADORA1 protein] Adenosine binds to ADORA1 protein [lead acetate results in increased expression of ADORA1 protein] which results in increased abundance of Adenosine; Adenosine analog binds to and results in increased activity of ADORA1 protein
|
CTD |
PMID:10649980 PMID:11520205 PMID:18404447 PMID:20571079 PMID:20932874 |
|
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Adora2a
|
adenosine A2a receptor
|
multiple interactions affects binding
|
ISO
|
Adenosine analog binds to and results in decreased activity of ADORA2A protein; Adenosine promotes the reaction [Lipopolysaccharides results in increased expression of ADORA2A mRNA] Adenosine binds to ADORA2A protein
|
CTD |
PMID:18404447 PMID:20067761 |
|
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802
|
|
| G
|
Adora2b
|
adenosine A2B receptor
|
affects response to substance
|
ISO
|
ADORA2B protein affects the susceptibility to Adenosine
|
CTD |
PMID:16920807 |
|
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091
|
|
| G
|
Adora3
|
adenosine A3 receptor
|
multiple interactions affects binding increases expression
|
ISO
|
Adenosine analog binds to and affects the activity of ADORA3 protein; Adenosine analog binds to and results in decreased activity of ADORA3 protein; Adenosine analog binds to and results in increased activity of ADORA3 protein; PD 81723 affects the reaction [Adenosine analog binds to and affects the activity of ADORA3 protein]; VUF 5455 affects the reaction [Adenosine analog binds to and affects the activity of ADORA3 protein] Adenosine binds to ADORA3 protein Adenosine results in increased expression of ADORA3 mRNA
|
CTD |
PMID:11520205 PMID:18404447 PMID:20067761 PMID:20571079 |
|
NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:196,077,042...196,080,686
|
|
| G
|
Alpi
|
alkaline phosphatase, intestinal
|
multiple interactions
|
ISO
|
Adenosine inhibits the reaction [Methotrexate results in increased activity of ALPI protein]
|
CTD |
PMID:16598758 |
|
NCBI chr 9:95,221,314...95,224,780
Ensembl chr 9:95,221,314...95,224,780
|
|
| G
|
Ampd2
|
adenosine monophosphate deaminase 2
|
multiple interactions
|
ISO
|
[tofacitinib results in decreased expression of AMPD2 protein] which affects the abundance of Adenosine
|
CTD |
PMID:25496463 |
|
NCBI chr 2:198,395,767...198,408,514
Ensembl chr 2:198,395,768...198,408,796
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases localization multiple interactions
|
ISO
|
Adenosine results in increased localization of BAX protein Thymidine inhibits the reaction [Adenosine results in increased localization of BAX protein]
|
CTD |
PMID:11570579 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression multiple interactions
|
ISO
|
Adenosine results in decreased expression of BCL2L1 mRNA; Adenosine results in decreased expression of BCL2L1 protein Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 mRNA]; Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 protein]
|
CTD |
PMID:20063052 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Birc2
|
baculoviral IAP repeat-containing 2
|
decreases expression
|
ISO
|
Adenosine results in decreased expression of BIRC2 mRNA; Adenosine results in decreased expression of BIRC2 protein
|
CTD |
PMID:20063052 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
|
|
| G
|
Birc3
|
baculoviral IAP repeat-containing 3
|
decreases expression
|
ISO
|
Adenosine results in decreased expression of BIRC3 mRNA
|
CTD |
PMID:20063052 |
|
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
|
|
| G
|
Bmp2
|
bone morphogenetic protein 2
|
increases expression
|
ISO
|
Adenosine results in increased expression of BMP2 mRNA
|
CTD |
PMID:34070360 |
|
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760
|
|
| G
|
Bmp4
|
bone morphogenetic protein 4
|
increases expression multiple interactions
|
ISO
|
Adenosine results in increased expression of BMP4 mRNA N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Adenosine results in increased expression of BMP4 mRNA]; PSB603 inhibits the reaction [Adenosine results in increased expression of BMP4 mRNA]; ZM 241385 inhibits the reaction [Adenosine results in increased expression of BMP4 mRNA]
|
CTD |
PMID:34070360 |
|
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172
|
|
| G
|
Bmpr1a
|
bone morphogenetic protein receptor type 1A
|
increases expression
|
ISO
|
Adenosine results in increased expression of BMPR1A mRNA
|
CTD |
PMID:34070360 |
|
NCBI chr16:9,740,751...9,786,861
Ensembl chr16:9,742,875...9,786,861
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases activity
|
ISO EXP
|
Dipyridamole inhibits the reaction [Adenosine results in increased activity of CASP3 protein]; Thymidine inhibits the reaction [Adenosine results in increased activity of CASP3 protein]
|
CTD |
PMID:11570579 PMID:16469385 PMID:17303086 PMID:20063052 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp8
|
caspase 8
|
increases activity multiple interactions
|
ISO EXP
|
Adenosine results in increased activity of CASP8 protein Dipyridamole inhibits the reaction [Adenosine results in increased activity of CASP8 protein]
|
CTD |
PMID:16469385 PMID:17303086 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
increases activity multiple interactions
|
ISO EXP
|
Adenosine results in increased activity of CASP9 protein Thymidine inhibits the reaction [Adenosine results in increased activity of CASP9 protein]
|
CTD |
PMID:11570579 PMID:16469385 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Ccnb1
|
cyclin B1
|
affects expression
|
EXP
|
Adenosine affects the expression of CCNB1 protein
|
CTD |
PMID:19638569 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnd1
|
cyclin D1
|
increases expression
|
ISO EXP
|
Adenosine results in increased expression of CCND1 mRNA Adenosine results in increased expression of CCND1 protein
|
CTD |
PMID:19638569 PMID:34070360 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccne1
|
cyclin E1
|
increases expression
|
EXP
|
Adenosine results in increased expression of CCNE1 protein
|
CTD |
PMID:19638569 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Cd14
|
CD14 molecule
|
increases expression
|
ISO
|
Adenosine results in increased expression of CD14 mRNA
|
CTD |
PMID:21538184 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
decreases expression multiple interactions
|
ISO
|
Adenosine results in decreased expression of CFLAR mRNA; Adenosine results in decreased expression of CFLAR mRNA alternative form; Adenosine results in decreased expression of CFLAR protein Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA alternative form]; Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA]; Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR protein]
|
CTD |
PMID:17303086 |
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Cftr
|
CF transmembrane conductance regulator
|
increases activity multiple interactions
|
ISO
|
Adenosine results in increased activity of CFTR protein [Isoproterenol co-treated with Adenosine] results in increased activity of CFTR protein
|
CTD |
PMID:15039139 |
|
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
increases expression multiple interactions
|
ISO
|
Adenosine results in increased expression of CREB1 mRNA N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Adenosine results in increased expression of CREB1 mRNA]; PSB603 inhibits the reaction [Adenosine results in increased expression of CREB1 mRNA]; ZM 241385 inhibits the reaction [Adenosine results in increased expression of CREB1 mRNA]
|
CTD |
PMID:34070360 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
increases expression
|
ISO
|
Adenosine results in increased expression of CTNNB1 mRNA
|
CTD |
PMID:34070360 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Diablo
|
diablo, IAP-binding mitochondrial protein
|
increases expression multiple interactions
|
ISO
|
Adenosine results in increased expression of DIABLO mRNA; Adenosine results in increased expression of DIABLO protein Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO mRNA]; Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO protein]
|
CTD |
PMID:20063052 |
|
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265
|
|
| G
|
Dkk1
|
dickkopf WNT signaling pathway inhibitor 1
|
increases expression
|
ISO
|
Adenosine results in increased expression of DKK1 mRNA
|
CTD |
PMID:34070360 |
|
NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650
|
|
| G
|
Dpp4
|
dipeptidylpeptidase 4
|
decreases expression multiple interactions
|
ISO
|
Adenosine results in decreased expression of DPP4 mRNA; Adenosine results in decreased expression of DPP4 protein [Adenosine results in decreased phosphorylation of MAPK1 protein] which results in decreased expression of DPP4 mRNA; [Adenosine results in decreased phosphorylation of MAPK1 protein] which results in decreased expression of DPP4 protein; [Adenosine results in decreased phosphorylation of MAPK3 protein] which results in decreased expression of DPP4 mRNA; [Adenosine results in decreased phosphorylation of MAPK3 protein] which results in decreased expression of DPP4 protein
|
CTD |
PMID:16611738 |
|
NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422
|
|
| G
|
E2f1
|
E2F transcription factor 1
|
affects expression
|
EXP
|
Adenosine affects the expression of E2F1 protein
|
CTD |
PMID:19638569 |
|
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
|
|
| G
|
E2f3
|
E2F transcription factor 3
|
affects expression
|
EXP
|
Adenosine affects the expression of E2F3 protein
|
CTD |
PMID:19638569 |
|
NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725
|
|
| G
|
Egf
|
epidermal growth factor
|
increases expression multiple interactions
|
ISO
|
Adenosine results in increased expression of EGF mRNA Adenosine results in increased expression of and results in increased secretion of EGF protein
|
CTD |
PMID:34070360 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
| G
|
Esr1
|
estrogen receptor 1
|
increases expression
|
ISO
|
Adenosine results in increased expression of ESR1 protein
|
CTD |
PMID:29360751 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
increases expression
|
ISO
|
Adenosine results in increased expression of ESR2 protein
|
CTD |
PMID:29360751 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Fadd
|
Fas associated via death domain
|
decreases expression multiple interactions
|
ISO
|
Adenosine results in decreased expression of FADD mRNA Dipyridamole inhibits the reaction [Adenosine results in decreased expression of FADD mRNA]
|
CTD |
PMID:17303086 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Faslg
|
Fas ligand
|
increases expression multiple interactions
|
ISO
|
Adenosine results in increased expression of FASLG protein [Adenosine co-treated with Coformycin] results in decreased expression of FASL mRNA
|
CTD |
PMID:11992407 PMID:16419169 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fgf6
|
fibroblast growth factor 6
|
multiple interactions
|
ISO
|
Adenosine results in increased expression of and results in increased secretion of FGF6 protein
|
CTD |
PMID:34070360 |
|
NCBI chr 4:161,541,089...161,549,624
Ensembl chr 4:161,541,089...161,553,521
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
increases expression
|
ISO
|
Adenosine results in increased expression of FSHB protein
|
CTD |
PMID:29360751 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
Fzd3
|
frizzled class receptor 3
|
increases expression
|
ISO
|
Adenosine results in increased expression of FZD3 mRNA
|
CTD |
PMID:34070360 |
|
NCBI chr15:43,596,962...43,664,047
Ensembl chr15:43,596,965...43,663,960
|
|
| G
|
Fzd5
|
frizzled class receptor 5
|
increases expression
|
ISO
|
Adenosine results in increased expression of FZD5 mRNA
|
CTD |
PMID:34070360 |
|
NCBI chr 9:73,606,860...73,614,039
Ensembl chr 9:73,606,860...73,618,612
|
|
| G
|
Gdnf
|
glial cell derived neurotrophic factor
|
increases secretion
|
ISO
|
Adenosine results in increased secretion of GDNF protein
|
CTD |
PMID:34070360 |
|
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
increases phosphorylation increases expression
|
ISO
|
Adenosine results in increased phosphorylation of GSK3B protein Adenosine results in increased expression of GSK3B mRNA
|
CTD |
PMID:34070360 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gzmb
|
granzyme B
|
multiple interactions
|
ISO
|
[Adenosine co-treated with Coformycin] results in decreased expression of GZMB mRNA
|
CTD |
PMID:11992407 |
|
NCBI chr15:34,459,007...34,462,469
Ensembl chr15:34,459,007...34,462,469
|
|
| G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
Adenosine promotes the reaction [Cesium-137 results in increased expression of and affects the localization of H2AX protein modified form]
|
CTD |
PMID:32941855 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
affects expression
|
EXP
|
Adenosine affects the expression of HGF protein
|
CTD |
PMID:19638569 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
increases expression
|
ISO
|
Adenosine results in increased expression of HIF1A mRNA
|
CTD |
PMID:20067761 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
increases abundance multiple interactions
|
ISO
|
IDH2 protein mutant form results in increased abundance of Adenosine Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Adenosine]
|
CTD |
PMID:27469509 |
|
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions
|
ISO
|
[Adenosine co-treated with Coformycin] results in decreased expression of IFNG protein
|
CTD |
PMID:11992407 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
affects expression multiple interactions
|
ISO
|
Adenosine affects the expression of IGF1 mRNA Adenosine results in increased expression of and results in increased secretion of IGF1 protein
|
CTD |
PMID:34070360 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf2
|
insulin-like growth factor 2
|
multiple interactions
|
ISO
|
Adenosine results in increased expression of and results in increased secretion of IGF2 protein
|
CTD |
PMID:34070360 |
|
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions increases expression
|
ISO
|
Adenosine promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] Adenosine results in increased expression of IL10 mRNA; Adenosine results in increased expression of IL10 protein
|
CTD |
PMID:11023991 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il12b
|
interleukin 12B
|
decreases expression multiple interactions
|
ISO
|
Adenosine results in decreased expression of IL12B protein Adenosine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL12B protein]
|
CTD |
PMID:11023991 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP
|
Adenosine inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Adenosine inhibits the reaction [IL1B protein results in increased expression of IL1R1]; Adenosine inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Adenosine inhibits the reaction [IL1B protein results in increased expression of NOS2 protein]
|
CTD |
PMID:24878381 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1r1
|
interleukin 1 receptor type 1
|
multiple interactions
|
EXP
|
Adenosine inhibits the reaction [IL1B protein results in increased expression of IL1R1]
|
CTD |
PMID:24878381 |
|
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579
|
|
| G
|
Il2
|
interleukin 2
|
multiple interactions
|
ISO
|
[Adenosine co-treated with Coformycin] results in decreased expression of IL2 protein
|
CTD |
PMID:11992407 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Lef1
|
lymphoid enhancer binding factor 1
|
increases expression
|
ISO
|
Adenosine results in increased expression of LEF1 mRNA
|
CTD |
PMID:34070360 |
|
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929
|
|
| G
|
Ly96
|
lymphocyte antigen 96
|
increases expression
|
ISO
|
Adenosine results in increased expression of LY96 mRNA
|
CTD |
PMID:21538184 |
|
NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816
|
|
| G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
increases phosphorylation
|
ISO
|
Adenosine results in increased phosphorylation of MAP2K1 protein
|
CTD |
PMID:34070360 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
|
|
| G
|
Map2k2
|
mitogen activated protein kinase kinase 2
|
increases phosphorylation
|
ISO
|
Adenosine results in increased phosphorylation of MAP2K2 protein
|
CTD |
PMID:34070360 |
|
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions decreases phosphorylation
|
ISO
|
[Adenosine results in decreased phosphorylation of MAPK1 protein] which results in decreased expression of DPP4 mRNA; [Adenosine results in decreased phosphorylation of MAPK1 protein] which results in decreased expression of DPP4 protein
|
CTD |
PMID:16611738 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases phosphorylation multiple interactions
|
ISO
|
Adenosine results in decreased phosphorylation of MAPK3 protein [Adenosine results in decreased phosphorylation of MAPK3 protein] which results in decreased expression of DPP4 mRNA; [Adenosine results in decreased phosphorylation of MAPK3 protein] which results in decreased expression of DPP4 protein
|
CTD |
PMID:16611738 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
increases expression
|
EXP
|
Adenosine results in increased expression of MET protein
|
CTD |
PMID:19638569 |
|
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
affects expression increases expression
|
ISO EXP
|
Adenosine affects the expression of MKI67 mRNA Adenosine results in increased expression of MKI67 protein
|
CTD |
PMID:19638569 PMID:34070360 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
increases phosphorylation
|
ISO
|
Adenosine results in increased phosphorylation of MTOR protein
|
CTD |
PMID:34070360 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Adenosine results in decreased expression of MYC protein Thymidine inhibits the reaction [Adenosine results in decreased expression of MYC protein]; Uridine inhibits the reaction [Adenosine results in decreased expression of MYC protein] Adenosine results in increased expression of MYC mRNA Adenosine results in increased expression of MYC protein
|
CTD |
PMID:9808420 PMID:19638569 PMID:34070360 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
[Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Adenosine co-treated with Homocysteine] results in decreased expression of NFKBIA mRNA
|
CTD |
PMID:24224954 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
decreases stability multiple interactions
|
EXP
|
Adenosine results in decreased stability of NOS2 mRNA Adenosine inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Adenosine inhibits the reaction [IL1B protein results in increased expression of NOS2 protein]
|
CTD |
PMID:24878381 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nt5e
|
5' nucleotidase, ecto
|
multiple interactions
|
ISO
|
[alpha,beta-methyleneadenosine 5'-diphosphate results in decreased activity of NT5E protein] inhibits the reaction [Oxygen deficiency results in increased abundance of Adenosine]
|
CTD |
PMID:23437309 |
|
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
increases expression
|
EXP
|
Adenosine results in increased expression of PCNA protein
|
CTD |
PMID:19638569 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pgf
|
placental growth factor
|
increases secretion
|
ISO
|
Adenosine results in increased secretion of PGF protein
|
CTD |
PMID:34070360 |
|
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
increases expression
|
ISO
|
Adenosine results in increased expression of PPARGC1A mRNA
|
CTD |
PMID:23056435 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Prf1
|
perforin 1
|
multiple interactions
|
ISO
|
[Adenosine co-treated with Coformycin] results in decreased expression of PRF1 mRNA
|
CTD |
PMID:11992407 |
|
NCBI chr20:29,789,040...29,794,550
Ensembl chr20:29,788,972...29,795,124
|
|
| G
|
Ptgdr
|
prostaglandin D2 receptor
|
multiple interactions
|
ISO
|
[Prostaglandin D2 results in increased activity of PTGDR protein] which results in increased metabolism of Adenosine; [Prostaglandin D2 results in increased activity of PTGDR protein] which results in increased secretion of Adenosine
|
CTD |
PMID:11562489 |
|
NCBI chr15:19,790,499...19,797,873
Ensembl chr15:19,790,499...19,797,873
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
[Adenosine co-treated with Homocysteine] affects the reaction [TNF protein affects the localization of RELA protein modified form]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of RELA protein]
|
CTD |
PMID:24224954 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Ren
|
renin
|
decreases secretion
|
EXP
|
Adenosine results in decreased secretion of REN protein
|
CTD |
PMID:3044993 |
|
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543
|
|
| G
|
Ripk1
|
receptor interacting serine/threonine kinase 1
|
multiple interactions
|
ISO
|
[Adenosine co-treated with Homocysteine co-treated with TNF protein] results in increased cleavage of RIPK1 protein
|
CTD |
PMID:24224954 |
|
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167
|
|
| G
|
Rps6kb1
|
ribosomal protein S6 kinase B1
|
increases phosphorylation
|
ISO
|
Adenosine results in increased phosphorylation of RPS6KB1 protein
|
CTD |
PMID:34070360 |
|
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238
|
|
| G
|
Slc28a1
|
solute carrier family 28 member 1
|
affects transport multiple interactions
|
ISO
|
SLC28A1 protein affects the transport of Adenosine Adenosine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]
|
CTD |
PMID:9124315 |
|
NCBI chr 1:144,490,453...144,532,025
Ensembl chr 1:144,490,623...144,531,544
|
|
| G
|
Slc28a2
|
solute carrier family 28 member 2
|
increases transport
|
ISO
|
SLC28A2 protein results in increased transport of Adenosine
|
CTD |
PMID:10087507 |
|
NCBI chr 3:129,778,425...129,841,292
Ensembl chr 3:129,807,537...129,841,291
|
|
| G
|
Slc29a1
|
solute carrier family 29 member 1
|
multiple interactions affects abundance increases uptake
|
ISO EXP
|
4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein alternative form results in increased uptake of Adenosine]; 4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]; [4-nitrobenzylthioinosine results in decreased activity of SLC29A1 protein] inhibits the reaction [Oxygen deficiency results in increased abundance of Adenosine]; [SLC29A1 co-treated with Oxygen deficiency] affects the abundance of Adenosine; Dipyridamole inhibits the reaction [SLC29A1 protein alternative form results in increased uptake of Adenosine]; Dipyridamole inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]; Dipyridamole promotes the reaction [[SLC29A1 co-treated with Oxygen deficiency] affects the abundance of Adenosine] SLC29A1 affects the abundance of Adenosine Adenosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine] SLC29A1 protein alternative form results in increased uptake of Adenosine; SLC29A1 protein results in increased uptake of Adenosine cilostazol inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]; Dipyridamole inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]; draflazine inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]; Ethanol promotes the reaction [SLC29A1 protein alternative form results in increased uptake of Adenosine]; Ethanol promotes the reaction [SLC29A1 protein results in increased uptake of Adenosine]; Ticagrelor inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]
|
CTD |
PMID:9353301 PMID:9396714 PMID:11179696 PMID:21283641 PMID:21872611 PMID:23437309 PMID:28041785 More...
|
|
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:22,902,471...22,914,620
|
|
| G
|
Slc29a2
|
solute carrier family 29 member 2
|
increases uptake
|
ISO
|
SLC29A2 protein results in increased uptake of Adenosine
|
CTD |
PMID:9396714 |
|
NCBI chr 1:211,756,588...211,764,561
Ensembl chr 1:211,757,000...211,764,560
|
|
| G
|
Slc29a3
|
solute carrier family 29 member 3
|
affects transport
|
ISO
|
SLC29A3 protein affects the transport of Adenosine
|
CTD |
PMID:19164483 |
|
NCBI chr20:29,191,086...29,228,299
Ensembl chr20:29,191,127...29,228,299
|
|
| G
|
Slc5a5
|
solute carrier family 5 member 5
|
increases expression
|
EXP
|
Adenosine results in increased expression of SLC5A5 mRNA; Adenosine results in increased expression of SLC5A5 protein
|
CTD |
PMID:16954431 |
|
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691
|
|
| G
|
Tgfa
|
transforming growth factor alpha
|
increases secretion
|
ISO
|
Adenosine results in increased secretion of TGFA protein
|
CTD |
PMID:34070360 |
|
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases expression
|
ISO
|
Adenosine results in increased expression of TGFB1 mRNA; Adenosine results in increased expression of TGFB1 protein
|
CTD |
PMID:34070360 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgfb2
|
transforming growth factor, beta 2
|
increases expression multiple interactions
|
ISO
|
Adenosine results in increased expression of TGFB2 mRNA Adenosine results in increased expression of and results in increased secretion of TGFB2 protein
|
CTD |
PMID:34070360 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
increases expression multiple interactions affects localization
|
ISO
|
Adenosine results in increased expression of TLR4 mRNA Adenosine promotes the reaction [lipopolysaccharide, E. coli O26-B6 affects the localization of TLR4 protein] Adenosine affects the localization of TLR4 protein
|
CTD |
PMID:21538184 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions decreases expression
|
ISO
|
5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine inhibits the reaction [Adenosine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein]]; [Adenosine co-treated with Homocysteine co-treated with TNF protein] results in increased cleavage of RIPK1 protein; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein affects the localization of RELA protein modified form]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of RELA protein]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein]; [Adenosine co-treated with Homocysteine] results in increased susceptibility to TNF protein; Adenosine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of TNF mRNA]; Adenosine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein]; ZM 241385 inhibits the reaction [Adenosine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein]] Adenosine results in decreased expression of TNF protein
|
CTD |
PMID:11023991 PMID:21538184 PMID:24224954 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfaip3
|
TNF alpha induced protein 3
|
multiple interactions
|
ISO
|
[Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein]; [Adenosine co-treated with Homocysteine] results in decreased expression of TNFAIP3 mRNA; [Adenosine co-treated with Homocysteine] results in decreased expression of TNFAIP3 protein
|
CTD |
PMID:24224954 |
|
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979
|
|
| G
|
Tnfsf10
|
TNF superfamily member 10
|
multiple interactions
|
ISO
|
[Adenosine co-treated with Coformycin] results in decreased expression of TNFSF10 mRNA
|
CTD |
PMID:11992407 |
|
NCBI chr 2:112,136,550...112,155,903
|
|
| G
|
Tp53bp1
|
tumor protein p53 binding protein 1
|
multiple interactions
|
ISO
|
Adenosine promotes the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein]
|
CTD |
PMID:32941855 |
|
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747
|
|
| G
|
Upp1
|
uridine phosphorylase 1
|
increases metabolic processing
|
ISO
|
UPP1 protein results in increased metabolism of Adenosine
|
CTD |
PMID:15772079 |
|
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:88,023,351...88,043,034
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions increases secretion increases expression
|
ISO
|
Adenosine promotes the reaction [Dipyridamole results in increased secretion of VEGFA protein]; Adenosine results in increased expression of and results in increased secretion of VEGFA protein Adenosine results in increased secretion of VEGFA protein Adenosine results in increased expression of VEGFA mRNA
|
CTD |
PMID:20067761 PMID:34070360 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|